36.5K
Downloads
248
Episodes
A Cure In Sight (ACIS) is a nonprofit organization committed to improving the lives of those affected by ocular melanoma. Through education, patient support programs, advocacy, and research funding, ACIS works to raise awareness and accelerate progress toward better treatments and outcomes.
The Eye Believe Podcast, hosted by A Cure In Sight, brings together patients, caregivers, researchers, and medical professionals to share stories, discuss advances in ocular melanoma research, and highlight the strength of the community. The podcast’s mission is to inform, inspire, and give a voice to those impacted by ocular melanoma.
Episodes
Tuesday Jan 20, 2026
Tuesday Jan 20, 2026
In this episode of the Eye Believe Podcast, we’re joined by Sophie Cantu, who shares her personal experience participating in a TIL (Tumor-Infiltrating Lymphocyte) clinical trial for ocular melanoma.
After previous treatments were unsuccessful, Sophie enrolled in the TIL trial—and saw encouraging results, including tumor shrinkage. She speaks candidly about what led her to the trial, what the experience was like, and how it changed her outlook moving forward.
Sophie’s story offers hope to patients and families navigating treatment decisions and highlights the importance of continued research and clinical trials in advancing options for ocular melanoma.
Tune in to hear Sophie’s journey, her perspective on perseverance, and why sharing patient experiences matters.
NCT pages for trials mentioned:
TIL TRIAL - https://www.clinicaltrials.gov/study/NCT03467516
IDEAYA TRIAL - https://www.clinicaltrials.gov/study/NCT05987332
RP2 TRIAL - https://clinicaltrials.gov/study/NCT06581406
Sophie Socials: https://www.facebook.com/SophieStevens9 https://www.instagram.com/sophiegstevenscantu/
No comments yet. Be the first to say something!